296 related articles for article (PubMed ID: 27479723)
1. Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis.
Bi N; Shedden K; Zheng X; Kong FS
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1378-1390. PubMed ID: 27479723
[TBL] [Abstract][Full Text] [Related]
2. Microsimulation model predicts survival benefit of radiofrequency ablation and stereotactic body radiotherapy versus radiotherapy for treating inoperable stage I non-small cell lung cancer.
Tramontano AC; Cipriano LE; Kong CY; Shepard JA; Lanuti M; Gazelle GS; McMahon PM
AJR Am J Roentgenol; 2013 May; 200(5):1020-7. PubMed ID: 23617484
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of stage IA non-small cell lung cancer in medically inoperable patients: Results from the American College of Surgeons Oncology Group Z4033 (Alliance) trial.
Dupuy DE; Fernando HC; Hillman S; Ng T; Tan AD; Sharma A; Rilling WS; Hong K; Putnam JB
Cancer; 2015 Oct; 121(19):3491-8. PubMed ID: 26096694
[TBL] [Abstract][Full Text] [Related]
4. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?
Bilal H; Mahmood S; Rajashanker B; Shah R
Interact Cardiovasc Thorac Surg; 2012 Aug; 15(2):258-65. PubMed ID: 22581864
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Stereotactic Body Radiation Therapy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Markov Modeling Study.
Pollom EL; Lee K; Durkee BY; Grade M; Mokhtari DA; Wahl DR; Feng M; Kothary N; Koong AC; Owens DK; Goldhaber-Fiebert J; Chang DT
Radiology; 2017 May; 283(2):460-468. PubMed ID: 28045603
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer.
Sher DJ; Wee JO; Punglia RS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e767-74. PubMed ID: 21300476
[TBL] [Abstract][Full Text] [Related]
7. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis.
Zhang R; Kang J; Ren S; Xing L; Xu Y
Ann Transl Med; 2022 Jan; 10(2):104. PubMed ID: 35282118
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic body radiation therapy and thermal ablation for treatment of NSCLC: A systematic literature review and meta-analysis.
Laeseke P; Ng C; Ferko N; Naghi A; Wright GWJ; Zhang Y; Laidlaw A; Kalsekar I; Laxmanan B; Ghosh SK; Zhou M; Szapary P; Pritchett M
Lung Cancer; 2023 Aug; 182():107259. PubMed ID: 37321074
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis.
Jeong Y; Lee KJ; Lee SJ; Shin YM; Kim MJ; Lim YS; Lee HC; Jung J; Park JH; Kim JH; Kim SY; Yoon SM
J Gastroenterol Hepatol; 2021 Jul; 36(7):1962-1970. PubMed ID: 33594690
[TBL] [Abstract][Full Text] [Related]
10. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
[TBL] [Abstract][Full Text] [Related]
11. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.
Zhao J; Yorke ED; Li L; Kavanagh BD; Li XA; Das S; Miften M; Rimner A; Campbell J; Xue J; Jackson A; Grimm J; Milano MT; Spring Kong FM
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1357-1366. PubMed ID: 27325482
[TBL] [Abstract][Full Text] [Related]
12. Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.
Verma V; Shostrom VK; Zhen W; Zhang M; Braunstein SE; Holland J; Hallemeier CL; Harkenrider MM; Iskhanian A; Jabbour SK; Attia A; Lee P; Wang K; Decker RH; McGarry RC; Simone CB
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):778-785. PubMed ID: 28244414
[TBL] [Abstract][Full Text] [Related]
13. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
[TBL] [Abstract][Full Text] [Related]
14. Treatment-Related Toxicity in Patients With Early-Stage Non-Small Cell Lung Cancer and Coexisting Interstitial Lung Disease: A Systematic Review.
Chen H; Senan S; Nossent EJ; Boldt RG; Warner A; Palma DA; Louie AV
Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):622-631. PubMed ID: 28581404
[TBL] [Abstract][Full Text] [Related]
15. Treatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete?
Dupuy DE
J Vasc Interv Radiol; 2013 Aug; 24(8):1139-45. PubMed ID: 23796858
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer.
Lanni TB; Grills IS; Kestin LL; Robertson JM
Am J Clin Oncol; 2011 Oct; 34(5):494-8. PubMed ID: 20805737
[TBL] [Abstract][Full Text] [Related]
17. The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer.
Allibhai Z; Taremi M; Bezjak A; Brade A; Hope AJ; Sun A; Cho BC
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1064-70. PubMed ID: 24210082
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
[TBL] [Abstract][Full Text] [Related]
19. Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis.
Aibe N; Yamazaki H; Nakamura S; Tsubokura T; Kobayashi K; Kodani N; Nishimura T; Okabe H; Yamada K
J Radiat Res; 2014 May; 55(3):575-82. PubMed ID: 24457315
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic Body Radiation Therapy Versus Surgery for Early Lung Cancer Among US Veterans.
Bryant AK; Mundt RC; Sandhu AP; Urbanic JJ; Sharabi AB; Gupta S; Daly ME; Murphy JD
Ann Thorac Surg; 2018 Feb; 105(2):425-431. PubMed ID: 29198624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
